Ajinomoto logo

Ajinomoto

Last updated January 31, 2026
72
Innovation Areas
1,635
Inventors
14
Collaborations

Modified deamidase and dehydrogenase biocatalysts: AjinomotoRecent Research Landscape

Low catalytic efficiency and poor thermal stability in wild-type enzymes limit the industrial synthesis of bioactive dipeptides. These engineered protein variants stabilize the enzymatic conversion process to increase yield and purity.

What technical problems is Ajinomoto addressing in Modified deamidase and dehydrogenase biocatalysts?

Low biocatalytic conversion efficiency

(3)evidences

Natural enzymes often suffer from poor thermal stability and low conversion rates in industrial synthesis. Overcoming these limitations increases the commercial viability of producing bioactive peptides and amino acids.

Poor plant protein solubility

(1)evidences

Inefficient extraction and synthesis of glycomacropeptides from complex protein sources. Increasing recovery rates and purity levels improves commercial viability for specialized nutritional applications.